Skip to content

Effects of GnRH agonist for luteal support on improvement of IVF/ICSI cycles

Effects of GnRH agonist for luteal support on improvement of IVF/ICSI cycles

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20160722029027N6
Enrollment
240
Registered
2018-09-20
Start date
2018-03-21
Completion date
Unknown
Last updated
2018-10-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Noninflammatory disorders of female genital tract. Complication associated with artificial fertilization, unspecified

Interventions

Intervention 1: Intervention group: Subcutaneous injection of Triptorelin (0.1 mg) 6 and 9 days after ICSI. Intervention 2: Control group: Subcutaneous injection of placebo(Normal saline) 6 and 9 days

Sponsors

Shahid Beheshti University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 38 Years

Inclusion criteria

Inclusion criteria: Age between 20-38 years old Body mass index (BMI) between 20-30 Fresh embryo transfer cycles 3rd menstrual day serum FSH below 10 Absence of low ovarian response according Bologna Criteria

Exclusion criteria

Exclusion criteria: Unwillingness to continue Absence of good quality embryo Ovarian hyper stimulation (more than 18 mature follicle during ovarian stimulation)

Design outcomes

Primary

MeasureTime frame
Clinical pregnancy. Timepoint: 4 weeks after embryo transfer. Method of measurement: Transvaginal ultrasound.;Chemical pregnancy. Timepoint: 2 weeks after embryo transfer. Method of measurement: Serum BHCG.

Secondary

MeasureTime frame
Ongoing pregnancy. Timepoint: 10 weeks after embryo transfer. Method of measurement: Fetal heart beat in ultrasound.;Abortion. Timepoint: Before 20 weeks of pregnancy. Method of measurement: Fetal demise before 20 weeks of gestation.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactLeila Nazari

Shahid Beheshti University of Medical Sciences

nazari@sbmu.ac.ir+98 21 2243 2558

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026